Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Cyperus rotundus essential oil effectively treats underarm darkening, reduces inflammation, and slows hair growth.

Combining fat grafts with botulinum toxin helps improve Raynaud's symptoms.

The P133R mutation in AKR1D1 enzyme causes harmful bile acid buildup, explaining related health issues.

Thyroid receptor β can help develop new drugs to treat hair loss.

New drugs like clonidine and prazosin show promise for treating high blood pressure despite some side effects.

TMPRSS2 is crucial for COVID-19 infection and is a potential target for treatment.

GRF is not safe for tubal occlusion.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

Mimicking the steroid A-ring may help create effective enzyme inhibitors for prostate disease treatment.

A prostate cancer drug can lower the levels of a protein that the coronavirus uses to enter lung cells.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Both oral contraceptives reduced acne effectively and had similar positive effects on skin oiliness and hair growth.

Many drugs can cause lipid metabolism issues, and labels need better warnings.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

The document concludes that biotin, folate, and RGD peptides are promising for targeting cancer cells with prodrugs, but the conjugates are not yet tested for use.

The new cocrystal KET-PABA is a more effective and safe anti-inflammatory treatment for skin conditions in mice.

Two patients treated with TAC for mouth fibrosis improved but developed Cushing's Syndrome symptoms.

Adding diltiazem to a beta blocker can cause dangerously slow heart rates.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

EGFR and mTOR inhibitors may help manage Olmsted syndrome symptoms.

Using CDK inhibitors on rats showed a reduction in chemotherapy-caused hair loss, but later experiments could not repeat these results.

Using GnRHa agonists helps diagnose and treat ovarian hyperthecosis when surgery isn't possible.

Pulsatilla chinensis compounds may help prevent stress-related hair loss.

Intranasal delivery of gene therapy shows promise for treating ischemic stroke.

HPH-15, a new compound, effectively reduces skin fibrosis in experiments without causing harm.

Rosemary extract helps skin heal faster by activating a specific receptor.

More research is needed to confirm the long-term effects of oral drugs for chronic central serous chorioretinopathy.